Stay updated on ComparisonType2DiabetesGPvsEndocrinologistClinicalTrial
Sign up to get notified when there's something new on the ComparisonType2DiabetesGPvsEndocrinologistClinicalTrial page.

Latest updates to the ComparisonType2DiabetesGPvsEndocrinologistClinicalTrial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page now displays the study record for the observational study of dapagliflozin use in people with type 2 diabetes, including study details and participation criteria, instead of a Forbidden error page.SummaryDifference45%

- Check7 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces an NIH-wide terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now shows a 403 Forbidden message instead of the study record details for the NCT03209089 entry, effectively replacing the study content with an access error; the header and footer remain visible.SummaryDifference17%

Stay in the know with updates to ComparisonType2DiabetesGPvsEndocrinologistClinicalTrial
Enter your email address, and we'll notify you when there's something new on the ComparisonType2DiabetesGPvsEndocrinologistClinicalTrial page.